Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia
NCT ID: NCT06051383
Last Updated: 2025-01-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2023-06-01
2024-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Research hypothesis:
To fulfill the aim of this study, the following research hypothesis was formulated:
Patients with benign prostatic hyperplasia will suffer less lower urinary tract symptoms (LUTS) after conducting self-management intervention than before conducting.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Interest of a Systematic Assessment of the Treatment of LUTS in the Management of BPH
NCT03179670
A Self-Administered Maneuver to Relieve Symptoms Suggestive of Benign Prostatic Hyperplasia
NCT01387893
Open Randomized Clinical Trial to Evaluate the Effects of Intermittent Caloric Restriction in Patients With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
NCT03669692
Protocollo N 2014 - Benign Prostatic Hyperplasia
NCT06182189
A Pilot Study Of The ALPFA Benign Prostatic Hyperplasia (BPH) Pulsed Field Ablation (PFA) System
NCT06965582
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study was conducted at Assiut Urology and Nephrology Hospital. A purposive sample of 60 adult male patients diagnosed with benign prostatic hyperplasia were older than 40 years old, had no other factors influencing their urination, such as prostate cancer.
Patients had been assessed at base line using the following tools:
Tool (I): A structured interview questionnaire. Tool (II): International Prostate Symptom Score (IPSS).
Each patient will be assessed before conducting self-management intervention for socio-demographic data, clinical data, and patients' knowledge regarding self-management using the tool I.
Each patient will be assessed for lower urinary tract symptoms before conducting self-management intervention using tool tool II(IPSS).
IPSS is a scoring system used to screen for and diagnose BPH as well as to monitor symptoms and guide decisions about how to manage the disease monitor lower urinary tract symptoms, It includes seven questions, about symptom of BPH.Each question had a range from 0 to 5 for its answer. Maximum score of 35 points. On the basis of total score, the symptoms were categorized into mild (0 -7), moderate (8-19), and severe (20-35).
After 3 months from conducting self-management intervention each patient was reassessed for clinical progression "severity" of lower urinary tract symptoms(LUTS)using (tools II).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
single group
Research design:
Quasi-experimental, single group pre- posttest design was utilized in the study. all patients will be assessed for LUTS at base line then will be reassessed after three months.
Study variables:
The independent variable is self management intervention while the dependent variable is the severity of lower urinary tract symptoms.
Self management
patients will be assessed at base line using tool I,II Patients will receive self-management intervention in the form of sessions. Four to six patients in each session. Each session will last approximately 20 minutes
Session 1 :
* Introduction to the concept of self-management.
* Education/reassurance
* Managing fluid intake.
* Caffeine abstinence
* Alcohol advice
Session 2 :
* Adjusting medications
* Constipation advice.
* Strategies for dribbling. pelvic floor exercise.
* Double-voiding.
* Bladder re-training.
Session 3:
• Booster session All sessions are supported with a self-management booklet given in session. All patients will be reassessed after three months
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Self management
patients will be assessed at base line using tool I,II Patients will receive self-management intervention in the form of sessions. Four to six patients in each session. Each session will last approximately 20 minutes
Session 1 :
* Introduction to the concept of self-management.
* Education/reassurance
* Managing fluid intake.
* Caffeine abstinence
* Alcohol advice
Session 2 :
* Adjusting medications
* Constipation advice.
* Strategies for dribbling. pelvic floor exercise.
* Double-voiding.
* Bladder re-training.
Session 3:
• Booster session All sessions are supported with a self-management booklet given in session. All patients will be reassessed after three months
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Men.
* Clinical diagnosis of benign prostatic hyperplasia.
Exclusion:
* Prostate cancer.
* Severe symptoms necessitating surgical treatment.
* Uncontrolled diabetes.
* End-stage cardiac disease or respiratory failure.
40 Years
65 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Amna A. Desouky, MD
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Amna A. Desouky, MD
Assistant Professor of Medical Surgical Nursing
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Nursing
Asyut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Self-management
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.